A Randomized Double Blind Clinical Trial in Famotidine Adjuvant Therapy in Schizophrenia


Background: About 40%-60% of schizophrenic patients are resistant to ordinary treatment, which result from interference with different neurotransmitter systems in the process of disease. The aim of present study was to determine the effect of famotidine on several symptoms of schizophrenia which was nonresponsive to neuroleptic treatment. Methods: 30… (More)

3 Figures and Tables


  • Presentations referencing similar topics